Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Nutrinia logo — company profile

Nutrinia

Founded 2003 Israel Israel 3 employees Series D Total: $43.00M Biotechnology, Developer Tools +2

General Information

Company Name Nutrinia
Founded Year 2003
Location Israel Israel
Employees 3
Industries Biotechnology, Developer Tools, Health Care +1
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with Nutrinia. To contact Nutrinia, visit nutrinia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Nutrinia compare?

A PDF of Nutrinia and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Nutrinia soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Nutrinia

Nutrinia is a neonatology focused company founded in 2003 and headquartered in Israel. The company is dedicated to treating rare conditions of the gastrointestinal tract. Nutrinia is currently developing pharmaceuticals, particularly oral formulations of insulin, that have shown promise in enhancing the adaptation and rehabilitation of the gut in infants. Their work is driven by the belief that science should be utilized to improve the lives of people, especially the most vulnerable populations.

Notably, Nutrinia secured a $30.00M Series D investment on 18 August 2016. The investors in this round included H.I.G. BioHealth Partners, Pontifax, OrbiMed, WuXi Healthcare Ventures, and TPG Biotech.

The company operates within the biotechnology, developer tools, health care, and information technology industries.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $30.00M 5
H.I.G. BioHealth Partners Pontifax OrbiMed
H.I.G. BioHealth Partners, Pontifax +3
18 Aug 2016
Series C $12.00M 2
Pontifax OrbiMed
Pontifax, OrbiMed
08 Dec 2014
Series A $1.00M 1
New Generation Technologies
22 Jun 2005

FAQ About Nutrinia

NUTRINIA IS A NEONATOLOGY FOCUSED COMPANY THAT TREATS RARE CONDITIONS OF THE GASTROINTESTINAL TRACT. Nutrinia is developing pharmaceuticals to treat rare conditions of the gastrointestinal tract. Our current products in development are oral formulations of insulin shown to enhance adaptation and...
Nutrinia was founded in 2003.
Nutrinia is headquartered in Israel.
Nutrinia operates in Biotechnology, Developer Tools, Health Care and Information Technology.
Nutrinia has approximately 3 employees.
Nutrinia has completed 3 funding rounds, raising a total of $43.00M. The latest funding stage is Series D.

We're actively collecting intelligence on Nutrinia.

Source: BounceWatch company record for Nutrinia, https://bouncewatch.com/company/nutrinia, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes